Review Article | Open Access
Peter de Cock, Kauko Mäkinen, Eino Honkala, Mare Saag, Elke Kennepohl, Alex Eapen, "Erythritol Is More Effective Than Xylitol and Sorbitol in Managing Oral Health Endpoints", International Journal of Dentistry, vol. 2016, Article ID 9868421, 15 pages, 2016. https://doi.org/10.1155/2016/9868421
Erythritol Is More Effective Than Xylitol and Sorbitol in Managing Oral Health Endpoints
Objective. To provide a comprehensive overview of published evidence on the impact of erythritol, a noncaloric polyol bulk sweetener, on oral health. Methods. A literature review was conducted regarding the potential effects of erythritol on dental plaque (biofilm), dental caries, and periodontal therapy. The efficacy of erythritol on oral health was compared with xylitol and sorbitol. Results. Erythritol effectively decreased weight of dental plaque and adherence of common streptococcal oral bacteria to tooth surfaces, inhibited growth and activity of associated bacteria like S. mutans, decreased expression of bacterial genes involved in sucrose metabolism, reduced the overall number of dental caries, and served as a suitable matrix for subgingival air-polishing to replace traditional root scaling. Conclusions. Important differences were reported in the effect of individual polyols on oral health. The current review provides evidence demonstrating better efficacy of erythritol compared to sorbitol and xylitol to maintain and improve oral health.
Erythritol is a four-carbon polyol (sugar alcohol) that shares many of the functional properties that are typical for the polyols family (e.g., sorbitol, xylitol). Such characteristics are important in practical applications of erythritol and include the following general features: relatively high stability in acidic and alkaline environments, high stability against heat, sweetness close to that of sucrose, calorific reduction compared to sucrose, safety, no cariogenic potential, low glycemic index, and suitability as a bulking agent in food manufacturing . Erythritol differentiates from all other polyols in that it is commercially produced using fermentation, a recognized natural process. Erythritol has been reported to have approximately 60–80% of the sweetness of sugar [2, 3], while contributing no calories (noncaloric) and having good digestibility (well tolerated) without any impact on blood glucose and insulin levels .
A significant volume of toxicology and safety studies exists, showing a complete lack of adverse effects associated with consumption of erythritol . This body of evidence demonstrating the safety of erythritol, combined with its zero-calorie sweetness and mouth feel, is all key contributors to the general acceptance by consumers for use in a wide variety of food products [5, 6].
While known for its nutritional and technological benefits, erythritol has also been shown to exert a number of beneficial oral health effects (summarized in Table 1). Specifically, the noncariogenicity of erythritol was established first in rats by a group of researchers in 1992 .
|GTF: glucosyltransferase; FTF: fructosyltransferase.|
Inclusion of erythritol in studies aimed at investigating the effects of polyols on dental caries followed the logical scientific process: other common polyols, notably xylitol and sorbitol, both of which are commonly used as sugar replacers in food products, had for dozens of years been studied as potential caries-preventive agents. Inventions related to erythritol manufacturing and comprehensive safety conclusions of the metabolic effects of erythritol have marked its gradual advent in the real world of consumers. The palette of polyol sweeteners has been expanding and may be nearing completion, since the number of physiologically acceptable polyol sweeteners can be considered limited. Erythritol may be regarded as a welcome addition to this palette.
The present review deals with erythritol primarily from the oral health perspective.
2. Regulatory Status of Erythritol
Erythritol has a significant history of safe use, with products being consumed in the marketplace since 1990 after being authorized for use in foods in many countries including Japan, USA, Canada, Brazil, Argentina, Paraguay, Uruguay, China, India, Israel, Mexico, Philippines, Singapore, Australia, New Zealand, South-Korea, Taiwan, and Thailand. Erythritol is currently approved for use in foods and beverages and marketed in more than 60 countries around the world . Euromonitor  has published consumption levels of erythritol from 2007 through 2012. The results show that on a worldwide basis the consumption levels of erythritol in 2012 accounted for approximately 25,500 metric tons and this level had been increasing steadily throughout this time period. This is highlighted specifically in the United States, which is the major consumer of erythritol, accounting for more than 13,000 metric tons in 2012 having grown from a value of 1,800 metric tons in 2007 (data from Euromonitor ).
3. Safety of Erythritol
A thorough safety evaluation of erythritol appeared in October 1996 in Regulatory Toxicology and Pharmacology (Volume 24, Number 2). The fifteen publications [4, 20–33] included in this safety review of erythritol demonstrate that erythritol is well tolerated and does not cause any toxicologically relevant effects even after ingestion of larger quantities. The digestive tolerance studies of Tetzloff et al.  confirmed the safety of oral erythritol: repeated ingestion of erythritol at daily doses of 1 g/kg body weight was well tolerated by humans. Even when consumed under most severe conditions as a single bolus dose in a beverage within 15 minutes on an empty stomach, an erythritol dose of 0.7 g/kg body weight did not cause laxation in adults  nor in young (4–6 years of age) children . In comparison, the dose at which xylitol did not show a laxative effect in adults under the same severe conditions was about 0.3 g/kg bw . It is anticipated that the exposure to erythritol via oral healthcare products will be very low at approximately 0.1 g/kg body weight per day, which is only 10% of the reported well-tolerated dose in humans .
4. Erythritol Suppresses Harmful Bacteria and Reduces Biofilm (Dental Plaque)
Erythritol was investigated for its potential to inhibit the growth of bacteria in dental plaque (i.e., a biofilm of microbial accumulations, particularly S. mutans) [8–11, 13, 14, 16, 17], as summarized in Table 1 and described below.
Mäkinen et al. [8, 9] conducted 2 preliminary xylitol, erythritol, and sorbitol comparison studies looking at their effects on saliva and plaque levels of S. mutans. In the first study , 2 groups of 15 subjects (mean age of years) were given either xylitol- or erythritol-containing chewable tablets (10 tablets/day) for a period of 2 months with a daily polyol intake of 5.2 g. Xylitol, but not erythritol, showed a statistically significant reduction of dental plaque and saliva and plaque levels of S. mutans. In the second study , subjects also were given chewable tablets (10 tablets/day) that contained xylitol (), sorbitol (), xylitol-erythritol (), or sorbitol-erythritol () for up to 64 days. Total daily polyol consumption was 5.4 g/day (mixtures contained 2.7 g/day of each polyol). A significant reduction in plaque and saliva counts of S. mutans was demonstrated for xylitol alone and for the 1 : 1 xylitol mixture with erythritol. Since erythritol was not administered alone, it is not possible to determine erythritol’s contribution to this effect. However, the relative portion of S. mutans of total streptococci at endpoint was significantly higher in the sorbitol group compared with the sorbitol-erythritol group (). In fact, the relative portion of S. mutans of total streptococci at endpoint was at the same low level in the sorbitol-erythritol group as in the xylitol-erythritol group indicating a strong contribution of erythritol in the S. mutans-reducing effects.
Mäkinen et al.  conducted another study that was 3 times longer in duration (6 months) and the daily total polyol consumption was higher (7.0 g/day) with a cohort that was up to 2 times larger (–36) than the previous 2 studies. The teenage subjects (~17 years of age) were given 2 chewable tablets containing xylitol (), erythritol (), or sorbitol () to suck or chew 6 times daily and underwent examinations (dental evaluations and sample collection of plaque and saliva) prior to polyol exposure (baseline) and at 3 and 6 months. They also were given toothpaste to use containing the corresponding polyol. An untreated control group () was not given any tablets and was asked to “continue their customary oral hygiene and dietary practice during the study.” The groups showed no statistically significant differences with respect to age or caries experience at the start of the study. The results of this study showed a statistically significant reduction in dental plaque weight as well as a reduction in the levels of S. mutans in dental plaque and saliva of subjects using erythritol or xylitol, as shown in Figures 1 and 2, respectively. Notably, the erythritol group not only had a significantly lower plaque weight compared to the control () but also to the sorbitol and xylitol groups () after 6 months. Mäkinen et al.  additionally conducted in vitro tests with several strains of S. mutans in which 0.6 M erythritol, sorbitol, xylitol, or untreated media were incubated with the organism for up to 5 hours. Erythritol inhibited growth most effectively compared with the other polyols (Figures 3 and 4). The results shown in Figure 3 indicate that the effect of xylitol, sorbitol, and maltitol is based on their osmotic effects since the osmolarity (or water activity) is exactly the same for each concentration tested and there is no significant difference in absorbance. The impact of erythritol on growth reduction, however, is higher at the same osmolarity. There is an additional growth-reducing effect of erythritol that xylitol, sorbitol, and maltitol do not have. This may be associated with the ability of erythritol to easily pass the cell membrane passively and suppress growth via several pathways as suggested by Hashino et al.  where it interferes in some of the enzymatic pathways involved in the growth of S. mutans. Figure 4 provides a useful insight into how big the differences in growth reduction is between the polyols tested at the same weight/volume concentrations. To reduce the absorbance to, for example, 1, the gram amount of maltitol required to reduce growth to that level is about 7x higher compared to erythritol and for xylitol; it is about 3x higher.
Of interest was the observation that erythritol seemed to inhibit the growth of S. mutans by a mechanism that differs from that of xylitol. Normally, xylitol-dependent inhibition of bacterial growth has appeared throughout the entire growth phase, whereas erythritol also inhibited—quite distinctly—the growth of some S. mutans strains during later growth phases. Both polyols were considered to have significant utility value in limiting the incidence of dental caries.
In addition to its inhibition of the growth of Streptococcus, erythritol was found to decrease the adherence of polysaccharide-forming oral streptococci (14 strains tested: S. mutans (9), S. sanguinis (2), S. salivarius (2), and S. sobrinus (1)) in an in vitro study investigating the growth inhibition and adherence of cells to a smooth glass surface by 2 or 4% erythritol and xylitol . Both erythritol and xylitol, at a concentration of 4%, significantly reduced the glass surface adhesion of most of the polysaccharide-forming streptococci tested; S. mutans 10449 and S. sobrinus OMZ 176 were not affected. Growth inhibition was considered not to be associated with the magnitude of the decrease in adherence (for erythritol there was a trend () toward an association) indicating that cell adherence was via a mechanism that did not depend on growth inhibition.
In another published study, it was suggested that, when compared to xylitol, erythritol in low concentrations (0.5–2%) had a weaker effect on the bacterial growth and acid production of S. mutans, while having stronger effect at high concentrations (8–16%) . White et al.  incubated strains of S. mutans and S. sobrinus with xylitol or erythritol for 48 hours and measured optical density using confocal microscopy at 620 or 640 nm to determine bacterial growth. Both polyols inhibited growth completely: at 15% for erythritol and at 30% for xylitol. No synergistic effect was noted when the polyols were combined.
Inhibition of in vitro growth and adherence of bacteria and formation of biofilm occurred when 2 or 4% erythritol or xylitol was incubated with streptococci strains (S. mutans, S. sobrinus, or S. sanguinis) overnight in microtiter plates . Erythritol was found to be more effective than xylitol in inhibiting the growth of S. mutans (69–71% versus 66–68%). Similar to the findings of Söderling and Hietala-Lenkkeri , adherence to the polystyrene microplate, as indicated by 630 nm optical density readings, also was inhibited to a greater extent by erythritol, particularly at the higher concentration of 4%. As shown in Figure 5, erythritol showed a stronger inhibitory effect than xylitol on biofilm formation of all 3 streptococci strains (e.g., 31.32% versus 3.55% inhibition of S. mutans at a concentration of 4%). Similar inhibitory effects of erythritol at a concentration of 4% on S. mutans were also reported by Saran et al.  in 2015 who observed 56.45% and 36.42% inhibition of growth and biofilm formation, respectively.
In an in vitro investigation on the effects of polyols on the development of biofilm, Hashino et al.  reported that 10% erythritol had an inhibitory effect on the microstructure and metabolomic profiles of biofilm composed of Porphyromonas gingivalis and Streptococcus gordonii. The most effective reagent to reduce P. gingivalis accumulation onto S. gordonii substrata was erythritol, when compared with xylitol and sorbitol. The authors suggested that erythritol’s inhibitory effects function “via several pathways, including suppression of growth resulting from DNA and RNA depletion, attenuated extracellular matrix production, and alterations of dipeptide acquisition and amino acid metabolism.”
The mechanism by which erythritol inhibits growth and reduces adhesion of S. mutans was examined by Park et al.  through the evaluation of expression profiles of the glucosyltransferase (GTF) and fructosyltransferase (FTF) genes in S. mutans in the presence of erythritol. These genes are involved in sucrose metabolism by facilitating the polymerization of free glucose and fructose into glucans and fructans, respectively, which, in turn, act as an energy source and protective barrier against bacterial toxins and are involved in promoting adhesion of bacteria to dental surfaces. In addition, the ability of erythritol to affect adhesion of S. mutans to smooth surfaces (i.e., glass beads) was investigated. Initially, the growth of S. mutans was evaluated over 24 hours in the presence of 10% sucrose, erythritol, xylitol, sorbitol, or untreated control and showed that both erythritol and xylitol significantly () inhibited growth at a similar level (see Figure 6(a)). Adhesion values and the adhesion inhibition rate of S. mutans were significantly () reduced with erythritol and xylitol when compared with sucrose, but not control (water) or sorbitol (see Figure 6(b)). Erythritol and xylitol both significantly decreased the expression of 3 GTF genes and 1 FTF gene () compared to sucrose. The decreases seen with erythritol also were significantly decreased when compared with sorbitol and untreated control (see Figure 6(c)). Since erythritol inhibited the growth of S. mutans, reduced adhesion of S. mutans to smooth surfaces, and decreased the expression of genes involved in sucrose metabolism, the authors considered erythritol to have anticariogenic potential.
5. Erythritol Reduces the Risk of Dental Caries
By the beginning of the new millennium, preliminary information on the oral biology of common polyols had reached a stage that encouraged the undertaking of long-term clinical trials to investigate the effect of erythritol on the incidence and propagation of dental caries in humans. The first, and for the time being the only, long-term human caries trial using erythritol alone (no mixture with other polyols) was executed by Tartu University Institute of Stomatology in Tartu, Estonia, in 2008–2011 .
This study resulted from theoretical considerations that the relative effect of three common polyols (i.e., erythritol, xylitol, and sorbitol) on the incidence and propagation of dental caries should differ and reflect the number of hydroxyl groups present in the polyol molecules . Preliminary results obtained with erythritol in animal caries  and some oral biologic processes in humans [8–10] were encouraging and, therefore, the Tartu polyol double-blind randomized controlled prospective intervention trial was developed to compare the long-term usage of erythritol and xylitol candies with sorbitol candies in children.
At the start of the trial, 485 first and second grade school children (~8-9 years of age) from 10 schools were randomly divided into erythritol (), xylitol (), and sorbitol (control, ) groups. By the end of the 3-year trial, 374 children remained in the study . Those leaving the trial were not at school on examination days, changed schools, or did not wish to continue to participate in the study.
Teachers provided the children with four small chewable tablets containing erythritol, xylitol, or sorbitol to consume three times each school day (about 200 school days per year) resulting in a calculated daily polyol consumption level of about 7.5 g. The children were educated on oral hygiene and provided with a toothbrush and fluoride toothpaste every 6 months with a recommendation to brush their teeth more than once a day. For assessment, the children were assigned to one of 4 trained dental examiners and underwent double-blind clinical examinations at the start of the trial (baseline) and at 12, 24, and 36 months using the International Caries Detection and Assessment System (ICDAS II) .
At baseline and at 12 months, the caries indicators of the mixed dentition were similar among all groups. The ICDAS examinations showed that the number of dentin caries teeth and surfaces at the 24-month follow-up and the tooth surfaces at the 36-month follow-up was significantly lower in the mixed dentition in the erythritol group than in the xylitol group. Over the 3-year follow-up period, the erythritol group had significantly less tooth surfaces developing into enamel or dentin caries and significantly less enamel caries tooth surfaces developing into dentin caries when compared with sorbitol and xylitol (see Figure 7). Furthermore, the time of enamel or dentin caries lesions to develop and dentin caries to progress was significantly longer in the erythritol group compared with the other polyol groups. Taken together, this resulted in the erythritol group having 143 less dental treatments (tooth restorations by a dentist) as compared to control.
In 2014, 3 years following cessation of the polyol interventions, 364 of the children were reevaluated using the same procedures (ICDAS examination) used during the 3-year intervention study (Falony et al., manuscript submitted). No significant differences in decayed, missing, and filled teeth and surfaces between the intervention groups were noted; however, in the erythritol group, percentages of surfaces developing enamel/dentin caries or dentin caries or subject to dentist intervention were still reduced compared to the other groups (see Figure 8). Consequently, habitual usage of erythritol candies in this child cohort showed a slower and lower caries development compared to the xylitol and sorbitol groups.
As part of this study, but published separately , saliva and plaque were collected at time of dental examination for determination of salivary and plaque counts of S. mutans and salivary counts of Lactobacillus. At years 1 and 3, a significant reduction ( when compared with the baseline values) in the weight of freshly collected dental plaque of the subjects occurred in the group receiving erythritol with a reduction tendency at the 2-year examination, as shown in Figure 9. No such changes were found in groups receiving sorbitol or xylitol. Chemical analysis indicated that usage of the three polyols had no significant or consistent effect on the plaque levels of protein, glucose, glycerol, or calcium. However, after three years, the plaque of erythritol-receiving subjects contained significantly () smaller levels of acetic acid and propionic acid than that of subjects who had received xylitol or sorbitol. The plaque levels of lactic acid partly followed this same general pattern. The consumption of erythritol was also generally associated with significantly () lower counts of salivary and plaque S. mutans. The use of these polyols had no significant effect on salivary Lactobacillus levels. Three months after the end of the trial, a fourth group of children () was evaluated as an additional comparison group within the same age groups. In this comparison group, mean salivary S. mutans counts were significantly higher than in the erythritol and xylitol groups ( and 0.034, resp.), but not the sorbitol group. Taken together, these results suggested that habitual consumption of erythritol reduced the involvement of several oral biologic factors that have normally been associated with the initiation and propagation of dental caries. Consequently, these results were in congruence with the clinical caries observations reported by Honkala et al. .
With regard to erythritol, the anticariogenic results of the Honkala et al.  study were consistent with previous findings in experimental animals and human subjects. The xylitol results, however, were not so straightforward and did not show as strong of an effect as erythritol when compared with sorbitol. Few previous xylitol caries studies [42–45] used sorbitol as a control and those results did not consistently show that xylitol outperformed sorbitol. In terms of demonstrable effectiveness, there are some inconsistencies in the data between xylitol and sorbitol, making the determination of the more effective compound less clear. For this reason, both xylitol and sorbitol were commonly used to compare to erythritol, which consistently outperformed both.
It may also be possible that the consumption level of the polyols and especially the frequency of daily use of the saliva stimulants (only three teacher-supervised exposures) were too low in this child population and under the prevailing school-based program conditions to show a difference for xylitol versus sorbitol. Furthermore, (1) the polyol tablets had to be consumed at schools within a relatively short duration of the day, as stipulated by the school hours (children left school latest at 2 pm); (2) chewing gum used in most xylitol studies is a much better salivary flow stimulant  compared to the compressed tablets used in the Honkala et al.  study, which used tablets purposely to focus as much as possible on the pharmacological effects of the polyols; (3) the exposure to the school children was a very mild intervention that did not take place during weekends and vacations meaning that intervention was only for about 200 days per year; and (4) erythritol has a lower solubility and molecular weight than xylitol and, therefore, erythritol dissolves more slowly most likely resulting in longer exposure and diffuses faster and deeper into the dental plaque where it can better exercise its impact on microbes like S. mutans.
The results from Honkala et al. , Runnel et al. , and Falony et al. (manuscript submitted) investigations indicate that erythritol did show statistically significant differences from the other two polyols in terms of caries development and oral biologic processes. In these studies, erythritol turned out to be a potential caries-preventing dietary sucrose substitute with higher efficacy compared to sorbitol and xylitol.
Some reports have claimed nonefficaciousness of erythritol as a caries-limiting agent. Closer examination of the study designs involved has revealed serious generalizations and shortcomings. For example, in a review of a double-blind, cluster-randomized clinical trial in school children (~10 years of age) conducted by another group of researchers , Duane  commented that there was no evidence of caries reduction in a school xylitol and erythritol lozenge program. However, the overall length of the intervention period may have been too short (±190 intervention days in 9 months or ±380 intervention days in 21 months), while the frequency of use (3x per school day) and the amount of xylitol (4.7 g) and erythritol (4.5 g) seemed to be too low. Furthermore, final caries diagnoses were made 27 or 39 months after termination of the interventions, and the study subjects lived in a fluoridated area and exhibited low caries activity.
The clinical studies are summarized in Table 2.
6. Erythritol Supports Periodontal Therapy
Traditional subgingival root scaling using hand tools is considered “technically demanding” and “time consuming” and, if not done carefully, could lead to painful dental root tissue loss [48–52]. Air-polishing treatment with nonabrasive powders such as glycine powder can reduce tissue loss on root surfaces while causing less pain for patients . Since erythritol has similar abrasive properties and particle size to glycine and has a sweet taste and noncariogenic properties, it was studied for its potential use with air-polishing devices and compared with traditional root scaling methods .
In a randomized, controlled, parallel-group clinical trial, subjects underwent supportive periodontal therapy at the start of the trial (baseline) and after 3 months . Out of 39 subjects, there were 91 and 87 periodontal sites used in the test and control groups, respectively. In the erythritol test group, test sites were subgingivally treated for 5 seconds with an air-polishing device using erythritol. An experienced operator treated control sites with curettes until all subgingival deposits were removed. All remaining dentition was treated using standard supportive periodontal therapy. Based on a visual analog scale, patient’s tolerance was significantly better for sites treated with erythritol than those without. There were no differences in clinical outcomes between subgingival air-polishing with erythritol or traditional scaling except that patients tended to prefer air-polishing. More recently, Hägi et al.  published the results of a similar study, but over a period of 6 months, in which subjects underwent treatment at baseline and 3 and 6 months with subgingival low abrasive erythritol powder using an air-polishing device or repeated scaling and root planing at study sites identified at baseline as bleeding on probing positive sites with probing pocket depth of ≥0.4 mm but no detectable calculus. At baseline and 6 months, plaque index, bleeding on probing, probing pocket depth, clinical attachment level, and subgingival plaque were evaluated. In the 38 patients completing the study, both treatments produced significant reductions in bleeding on probing and probing pocket depth and increases in clinical attachment level. There were no statistically significant differences between the treatment groups.
In another study, subgingival air-polishing with erythritol containing 0.3% chlorhexidine was compared to ultrasonic debridement at 3-month intervals for up to 12 months . Fifty patients with 6,918 sites were examined at start of the study (baseline) and served as their own controls (i.e., one side was treated with erythritol air-polishing and one side with ultrasonic debridement). At the 12-month examination, there was no difference between the treatments with respect to the presence or absence of a probing depth >4 mm and the frequencies at >1,000 and >100,000 cell/mL of 6 microorganisms (Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Tannerella forsythia, Treponema denticola, Prevotella intermedia, and Parvimonas micra). However, at 12 months, erythritol-treated sites were less frequently positive for Aggregatibacter actinomycetemcomitans at >1,000 cell/mL with counts never exceeding 100,000 cells/mL. Moreover, air-polishing with erythritol was significantly better than ultrasonic debridement in terms of pain/discomfort perception.
An in vitro study was conducted to compare the efficacy of air-polishing with 99.7% erythritol/0.3% chlorhexidine versus standard glycine powder and their antimicrobial and antibiofilm potential on Staphylococcus aureus, Bacteroides fragilis, and Candida albicans . For each strain, 6 sandblasted titanium disks were used: 2 for air-polishing with water, 2 for air-polishing with glycine, and 2 for air-polishing with erythritol/chlorhexidine. The amount of biofilm was determined by spectrophotometric assay and biofilm residue was examined for microbial recovery. Erythritol/chlorhexidine was significantly more effective than glycine in inhibiting the growth of all 3 strains, reducing the number of surviving cells following air-polishing (15–30% for glycine, 50% for erythritol/chlorhexidine), and reducing the biofilm produced by all 3 strains.
The air-polishing studies are summarized in Table 3.
Erythritol is the newest polyol (sugar alcohol) used as a bulk sweetener in foods. It differs in many ways from all other polyols. It has the smallest molecular size as this polyol is of the tetritol type and it is the first polyol to be commercially produced by fermentation, a natural process . Its unique metabolic profile renders it to be noncaloric, nonglycemic, noninsulinemic, and very well tolerated. It has been consumed by animals and humans for ages as small quantities of erythritol occur widely in microorganisms, algae, fermented foods, lichens, mushrooms, many fruits and vegetables, and also animal and human tissues [5, 20, 57].
Unlike all other polyols including sorbitol and xylitol, ingested erythritol is rapidly and almost completely absorbed from the small intestine, not metabolized, and excreted unchanged in the urine . Depending on the quantity ingested, approximately 10% of ingested erythritol may reach the colon . Its high systemic bioavailability has been linked to additional health benefits for people with diabetes by reducing arterial stiffness and improving small vessel endothelial function .
Owing to its sweet taste and high digestive tolerance, erythritol is well suited to replace sugar pound-for-pound in foods without replacing any calories thereby significantly reducing the energy density of those foods. All dental and oral biological studies carried out to date have suggested erythritol to be noncariogenic. Erythritol is being used as a sweetener in dentally safe confectionery items, desserts, tabletop sweeteners, beverages, and many other sugar-free and calorie-reduced foods. Erythritol is authorized for use in foods in more than sixty countries and is included in the GSFA-list (General Standard for Food Additives) of the Codex Alimentarius under INS number 968.
The noncariogenicity of erythritol was first investigated and established in rats in 1990 [7, 58] and soon after in 1996 in humans . Early studies demonstrated that erythritol limits the growth, lactic acid production, and plaque formation of S. mutans (serotypes a–h)  and a number of other streptococci species [10, 14]. Erythritol did not serve as a substrate for cellular aggregation of S. mutans (serotypes d, g, and h) and was not utilized for water-insoluble glucan synthesis and cellular adherence by glucosyltransferase from S. mutans PS-14 (c) or S. sobrinus 6715 (g) . Moreover, erythritol decreased the adherence of polysaccharide-forming oral streptococci when present in growth media at levels as low as 2–4% [11, 14]. Most of the in vitro studies compared the impact of erythritol on inhibition of microbial growth and adhesion with one or more other polyols with mostly similar inhibitory effects when compared to xylitol and no effects for sorbitol. This was consistent with the findings in a 6-month human study investigating the effects of candies formulated with erythritol, xylitol, and sorbitol on premonitory symptoms of dental caries . In this study, the only difference in beneficial effects seen for erythritol and xylitol but not for sorbitol was a significant higher reduction in fresh plaque weight compared to baseline in subjects consuming erythritol (−30%) than those consuming xylitol (−13%). Such higher dental plaque reduction for erythritol versus xylitol was also seen in a 3-year caries study in 485 children comparing the effect of candies formulated with erythritol, xylitol, and sorbitol: a reduction in dental plaque was only demonstrated in the group of children consuming erythritol candies (−24%) but not in the xylitol or sorbitol group . This caries study further demonstrated a lower caries development in the erythritol group compared to the sorbitol and xylitol group after a 3-year intervention period  that was still visible even 3 years after the intervention was terminated (Falony et al., manuscript submitted). The results reported in these three publications showed that erythritol has caries-preventing activity with higher efficacy compared to sorbitol and xylitol. Broadly, the mechanisms through which the caries-preventing activity of erythritol is achieved are as follows:(i)Inhibition in growth and decreased acid production of the principle bacterial species associated with caries development like S. mutans.(ii)Decrease in adherence of common streptococcal oral bacteria to tooth surfaces, due, in part, to a decrease in expression of bacterial genes involved in sugar(s) metabolism resulting in a reduced production of glucans and fructans.(iii)Decrease in in vitro biofilm formation and in vivo dental plaque weight.Certain exposure conditions should be met in order to benefit from the caries-preventing activity of erythritol. The two short term studies by Mäkinen et al. in 2001 and 2002 [8, 9] that did not show plaque reduction used an intervention period of 2 months and used very fragile tablets that fragmented and dissolved in the mouth rapidly resulting in an exposure time of 1 to 2 minutes. The total daily dose of erythritol in both studies was 5.1 g and 2.7 g in 2001 and 2002, respectively. In addition, these tablets contained low use levels of erythritol: 39.5% and 24.5% in 2001 and 2002, respectively. The short exposure time combined with the rather low use level and low total daily dose of erythritol, as well as the short intervention period of 2 months, has likely contributed to the absence of a plaque reducing effect in these two studies. The caries study by Hietala-Lenkkeri et al. 2012  that did not show caries-preventive effects of erythritol and xylitol used lozenges containing 49.4% erythritol that were consumed 3 times daily resulting in a total dose of 4.5 g erythritol daily. The actual intervention duration was 9 and 18 months in the 2 groups investigated who were, respectively, examined 39 and 27 months after termination of the intervention. In addition, the study was done in an area with low caries prevalence: average DMFT for 12-year-olds was 0.8 in comparison with the average for Finland which is 1.2. This, and the rather low use level and low total daily dose of erythritol, as well as the short intervention period of maximally 18 months and the absence of a clinical examination immediately after the intervention, hs likely contributed to the absence of a caries reducing effect in this study.
The erythritol candies used in the human studies published by Mäkinen et al. , Runnel et al. , Honkala et al. , and Falony et al. (manuscript submitted) were conducted with pressed tablets/lozenges containing 90% erythritol and with a hardness similar to such candies on the market that take about 4 to 8 minutes of sucking time to dissolve in the mouth [46, 60]. In particular, the beneficial results from the 3-year caries study reported in the last 3 publications were achieved under the following exposure conditions:(1)Candies containing 90% erythritol.(2)Daily consumption of 7.5 g erythritol, divided over three consumptions of 2.5 g erythritol.(3)Candies with a hard texture resulting in an exposure time of about 4 minutes or more per eating occasion.(4)Consumption only during schooldays, so not during weekends or summer holiday (about 200 days per year).These exposure conditions are much in line with recommendations for xylitol chewing gum as published in the 2011 review by Mäkinen .
The present review summarizes the oral health benefits of erythritol use as demonstrated by a reduction in the overall number of dental caries and associated dental surface restorations (dentist treatments) when used routinely. It also can serve as a suitable matrix for subgingival air-polishing to replace traditional root scaling in periodontal therapy. The dental and oral biological studies on erythritol, xylitol, and sorbitol discussed have reemphasized important differences between the individual polyols. Polyols can therefore not be regarded as a single entity of organic molecules with exactly identical molecular parameters and similar biological effects. The evidence demonstrating better efficacy of erythritol compared to sorbitol and xylitol to maintain and improve oral health is growing and offers a clear distinction among polyols.
The authors Peter de Cock and Alex Eapen are employees of Cargill. The author Elke Kennepohl is a consultant to Cargill. The authors Kauko Mäkinen, Eino Honkala, and Mare Saag have no competing interests to declare.
- D. C. P. Erythritol, Sweeteners and Sugar Alternatives in Food Technology, Edited by K. O'Donnell, M. Kearsley, Wiley-Blackwell, 2012.
- K. Sugita and M. Yamazaki, “Sweetness of erythritol and its use for foodstuff,” Gakkuen (Internal report of Showa Women's University), 1988.
- J. Goossens and H. Röper, “Erythritol: a new bulk sweetener,” International Food Ingredients, vol. 1-2, pp. 27–33, 1994.
- F. R. J. Bornet, A. Blayo, F. Dauchy, and G. Slama, “Gastrointestinal response and plasma and urine determinations in human subjects given erythritol,” Regulatory Toxicology and Pharmacology, vol. 24, part 2, pp. S296–S302, 1996.
- I. C. Munro, W. O. Bernt, J. F. Borzelleca et al., “Erythritol: an interpretive summary of biochemical, metabolic, toxicological and clinical data,” Food and Chemical Toxicology, vol. 36, no. 12, pp. 1139–1174, 1998.
- JECFA, Safety Evaluation of Certain Food Additives and Contaminants, WHO Food Additive Series, No. 44, Joint FAO/WHO Expert Committee on Food Additives, 1999.
- J. Kawanabe, M. Hirasawa, T. Takeuchi, T. Oda, and T. Ikeda, “Noncariogenicity of erythritol as a substrate,” Caries Research, vol. 26, no. 5, pp. 358–362, 1992.
- K. K. Mäkinen, K. P. Isotupa, T. Kivilompolo, P. L. Mäkinen, J. Toivanen, and E. Söderling, “Comparison of erythritol and xylitol saliva stimulants in the control of dental plaque and mutans streptococci,” Caries Research, vol. 35, no. 2, pp. 129–135, 2001.
- K. K. Mäkinen, K. P. Isotupa, T. Kivilompolo et al., “The effect of polyol-combinant saliva stimulants on S. mutans levels in plaque and saliva of patients with mental retardation,” Special Care in Dentistry, vol. 22, no. 5, pp. 187–193, 2002.
- K. K. Mäkinen, M. Saag, K. P. Isotupa et al., “Similarity of the effects of erythritol and xylitol on some risk factors of dental caries,” Caries Research, vol. 39, no. 3, pp. 207–215, 2005.
- E. M. Söderling and A.-M. Hietala-Lenkkeri, “Xylitol and erythritol decrease adherence of polysaccharide-producing oral streptococci,” Current Microbiology, vol. 60, no. 1, pp. 25–29, 2010.
- J. Yao, J.-L. Zhang, Y.-Q. Wu, and Z.-J. Lu, “Contrasting study of erythritol and xylitol on Streptococcus mutans,” Hua Xi Kou Qiang Yi Xue Za Zhi, vol. 27, no. 6, pp. 603–605, 2009.
- K. White, C. Le, M. Cannon et al., “Inhibition of Streptococcus mutans and sobrinus by xylitol and erythritol (poster),” in Proceedings of the 93rd General Session of the International Association for Dental Research, Boston, Mass, USA, 2015.
- G. R. Ghezelbash, I. Nahvi, and M. Rabbani, “Comparative inhibitory effect of xylitol and erythritol on the growth and biofilm formation of oral Streptococci,” African Journal of Microbiology Research, vol. 6, no. 20, pp. 4404–4408, 2012.
- S. Saran, S. Mukherjee, J. Dalal, and R. K. Saxena, “High production of erythritol from Candida sorbosivorans SSE-24 and its inhibitory effect on biofilm formation of Streptococcus mutans,” Bioresource Technology, vol. 198, pp. 31–38, 2015.
- E. Hashino, M. Kuboniwa, S. A. Alghamdi et al., “Erythritol alters microstructure and metabolomic profiles of biofilm composed of Streptococcus gordonii and Porphyromonas gingivalis,” Molecular Oral Microbiology, vol. 28, no. 6, pp. 435–451, 2013.
- Y.-N. Park, S.-S. Jeong, J. Zeng et al., “Anti-cariogenic effects of erythritol on growth and adhesion of Streptococcus mutans,” Food Science and Biotechnology, vol. 23, no. 5, pp. 1587–1591, 2014.
- D. M. P. H. J. Boesten, G. J. M. den Hartog, P. de Cock, D. Bosscher, A. Bonnema, and A. Bast, “Health effects of erythritol,” Nutrafoods, vol. 14, no. 1, pp. 3–9, 2015.
- Euromonitor, Ingredients: Euromonitor International from Trade Interviews and Industry Sources, Euromonitor International Database, 2014.
- W. O. Bernt, J. F. Borzelleca, G. Flamm, and I. C. Munro, “Erythritol: a review of biological and toxicological studies,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, part 2, pp. S191–S197, 1996.
- B. A. R. Lina, M. H. M. Bos-Kuijpers, H. P. Til, and A. Bär, “Chronic toxicity and carcinogenicity study of erythritol in rats,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, pp. S264–S279, 1996.
- K. Noda, K. Nakayama, and J. Modderman, “Fate of erythritol after single oral administration to rats and dogs,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, pp. S206–S213, 1996.
- A. E. Smits-van Prooije, D. H. Waalkens-Berendsen, and A. Bär, “Embryotoxicity and teratogenicity study with erythritol in rats,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, part 2, pp. S232–S236, 1996.
- W. Tetzloff, F. Dauchy, S. Medimagh, D. Carr, and A. Bär, “Tolerance to subchronic, high-dose ingestion of erythritol in human volunteers,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, part 2, pp. S286–S295, 1996.
- H. P. Til, C. F. Kuper, H. E. Falke, and A. Bär, “Subchronic oral toxicity studies with erythritol in mice and rats,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, part 2, pp. S221–S231, 1996.
- H. P. Til and J. Modderman, “Four-week oral toxicity study with erythritol in rats,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, part 2, pp. S214–S220, 1996.
- B. Van Ommen, B. de Bie, and A. Bär, “Disposition of 14C-erythritol in germfree and conventional rats,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, pp. S198–S205, 1996.
- D. H. Waalkens-Berendsen, A. E. Smits-Van Prooije, M. V. M. Wijnands, and A. Bär, “Two-generation reproduction study of erythritol in rats,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, part 2, pp. S237–S246, 1996.
- M. Shimizu, M. Katoh, M. Imamura, and J. Modderman, “Teratology study of erythritol in rabbits,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, part 2, pp. S247–S253, 1996.
- I. Dean, F. Jackson, and R. J. Greenough, “Chronic (1-year) oral toxicity study of erythritol in dogs,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, part 2, pp. S254–S260, 1996.
- Y. Kawamura, Y. Saito, M. Imamura, and J. P. Modderman, “Mutagenicity studies on erythritol in bacterial reversion assay systems and in Chinese hamster fibroblast cells,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, part 2, pp. S261–S263, 1996.
- F. R. J. Bornet, A. Blayo, F. Dauchy, and G. Slama, “Plasma and urine kinetics of erythritol after oral ingestion by healthy humans,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, part 2, pp. S280–S285, 1996.
- M. Ishikawa, M. Miyashita, Y. Kawashima, T. Nakamura, N. Saitou, and J. Modderman, “Effects of oral administration of erythritol on patients with diabetes,” Regulatory Toxicology and Pharmacology, vol. 24, no. 2, part 2, pp. S303–S308, 1996.
- D. Storey, A. Lee, F. Bornet, and F. Brouns, “Gastrointestinal tolerance of erythritol and xylitol ingested in a liquid,” European Journal of Clinical Nutrition, vol. 61, no. 3, pp. 349–354, 2007.
- E. Jacqz-Aigrain, B. Kassai, C. Cornu et al., “Gastrointestinal tolerance of erythritol-containing beverage in young children: a double-blind, randomised controlled trial,” European Journal of Clinical Nutrition, vol. 69, no. 6, pp. 746–751, 2016.
- K. K. Mäkinen, “Sugar alcohol sweeteners as alternatives to sugar with special consideration of xylitol,” Medical Principles and Practice, vol. 20, no. 4, pp. 303–320, 2011.
- S. Honkala, R. Runnel, M. Saag et al., “Effect of erythritol and xylitol on dental caries prevention in children,” Caries Research, vol. 48, no. 5, pp. 482–490, 2014.
- K. K. Mäkinen, “Sugar alcohols, caries incidence, and remineralization of caries lesions: a literature review,” International Journal of Dentistry, vol. 2010, Article ID 981072, 23 pages, 2010.
- A. I. Ismail, W. Sohn, M. Tellez et al., “The International Caries Detection and Assessment System (ICDAS): an integrated system for measuring dental caries: Methods,” Community Dentistry and Oral Epidemiology, vol. 35, no. 3, pp. 170–178, 2007.
- R. Runnel, K. K. Mäkinen, S. Honkala et al., “Effect of three-year consumption of erythritol, xylitol and sorbitol candies on various plaque and salivary caries-related variables,” Journal of Dentistry, vol. 41, no. 12, pp. 1236–1244, 2013.
- A.-M. Hietala-Lenkkeri, K. Pienihäkkinen, S. Hurme, and P. Alanen, “The caries-preventive effect of xylitol/maltitol and erythritol/maltitol lozenges: results of a double-blinded, cluster-randomized clinical trial in an area of natural fluoridation,” International Journal of Paediatric Dentistry, vol. 22, no. 3, pp. 180–190, 2012.
- K. K. Mäkinen, C. A. Bennett, P. P. Hujoel et al., “Xylitol chewing gums and caries rates: a 40-month cohort study,” Journal of Dental Research, vol. 74, no. 12, pp. 1904–1913, 1995.
- K. K. Mäkinen, P. P. Hujoel, C. A. Bennett, K. P. Isotupa, P.-L. Mäkinen, and P. Allen, “Polyol chewing gums and caries rates in primary dentition: a 24-month cohort study,” Caries Research, vol. 30, no. 6, pp. 408–417, 1996.
- K. K. Mäkinen, D. Pemberton, P. L. Mäkinen et al., “Polyol-combinant saliva stimulants and oral health in Veterans Affairs patients—an exploratory study,” Special Care in Dentistry, vol. 16, no. 3, pp. 104–115, 1996.
- V. Machiulskiene, B. Nyvad, and V. Baelum, “Caries preventive effect of sugar-substituted chewing gum,” Community Dentistry and Oral Epidemiology, vol. 29, no. 4, pp. 278–288, 2001.
- C. Dawes and L. M. Macpherson, “Effects of nine different chewing-gums and lozenges on salivary flow rate and pH,” Caries Research, vol. 26, no. 3, pp. 176–182, 1992.
- B. G. Duane, “No evidence of caries reduction found in a school xylitol and erythritol lozenge programme,” Evidence-Based Dentistry, vol. 12, no. 4, pp. 102–103, 2011.
- T. F. Flemmig, G. J. Petersilka, A. Mehl, R. Hickel, and B. Klaiber, “The effect of working parameters on root substance removal using a piezoelectric ultrasonic scaler in vitro,” Journal of Clinical Periodontology, vol. 25, no. 2, pp. 158–163, 1998.
- T. T. Hägi, P. Hofmänner, G. E. Salvi, C. A. Ramseier, and A. Sculean, “Clinical outcomes following subgingival application of a novel erythritol powder by means of air polishing in supportive periodontal therapy: a randomized, controlled clinical study,” Quintessence International, vol. 44, no. 10, pp. 753–761, 2013.
- T. Kocher, J. Fanghänel, H. Sawaf, and R. Litz, “Substance loss caused by scaling with different sonic scaler inserts—an in vitro study,” Journal of Clinical Periodontology, vol. 28, no. 1, pp. 9–15, 2001.
- L. Ritz, A. F. Hefti, and K. H. Rateitschak, “An in vitro investigation on the loss of root substance in scaling with various instruments,” Journal of Clinical Periodontology, vol. 18, no. 9, pp. 643–647, 1991.
- U. Zappa, B. Smith, C. Simona, H. Graf, D. Case, and W. Kim, “Root substance removal by scaling and root planing,” Journal of Periodontology, vol. 62, no. 12, pp. 750–754, 1991.
- R. Moëne, F. Décaillet, E. Andersen, and A. Mombelli, “Subgingival plaque removal using a new air-polishing device,” Journal of Periodontology, vol. 81, no. 1, pp. 79–88, 2010.
- T. T. Hägi, P. Hofmanner, S. Eick et al., “The effects of erythritol air-polishing powder on microbiologic and clinical outcomes during supportive periodontal therapy: six-month results of a randomized controlled clinical trial,” Quintessence International, vol. 46, no. 1, pp. 31–41, 2015.
- N. Müller, R. Moëne, J. A. Cancela, and A. Mombelli, “Subgingival air-polishing with erythritol during periodontal maintenance: randomized clinical trial of twelve months,” Journal of Clinical Periodontology, vol. 41, no. 9, pp. 883–889, 2014.
- L. Drago, M. Del Fabbro, M. Bortolin, C. Vassena, E. De Vecchi, and S. Taschieri, “Biofilm removal and antimicrobial activity of two different air-polishing powders: an in vitro study,” Journal of Periodontology, vol. 85, no. 11, pp. e363–e369, 2014.
- C. J. Carr and J. C. Krantz Jr., “Metabolism of the sugar alcohols and their derivatives,” Advances in Carbohydrate Chemistry, vol. 1, pp. 175–192, 1945.
- J. Kawanabe, “Non-cariogenicity of erythritol as a substrate,” Nichidai Koku Kagaku, vol. 16, no. 1, pp. 27–36, 1990.
- J. Goossens and M. Gonze, “Nutritional properties and applications of erythritol: a unique combination?” in Advances in Sweeteners, T. H. Grenby, Ed., pp. 150–186, Springer, Boston, Mass, USA, 1996.
- P. Lif Holgerson, C. Stecksén-Blicks, I. Sjöström, M. Öberg, and S. Twetman, “Xylitol concentration in saliva and dental plaque after use of various xylitol-containing products,” Caries Research, vol. 40, no. 5, pp. 393–397, 2006.
Copyright © 2016 Peter de Cock et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.